Dow Down 0.47% Nasdaq Up 0.41%

XOMA Corporation (XOMA)

-NasdaqGM
4.17 Up 0.14(3.60%) 10:12AM EDT - Nasdaq Real Time Price
Prev Close:4.03
Open:4.03
Bid:4.16 x 600
Ask:4.17 x 1000
1y Target Est:9.00
Beta:2.96
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.03 - 4.17
52wk Range:3.42 - 9.57
Volume:147,624
Avg Vol (3m):1,317,350
Market Cap:446.51M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMAUp 3.60%446.51M
NVSUp 0.62%211.49B
REGNDown 1.26%36.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.51
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback